whether abruptly stopping clopidogrel (Plavix) can worsen cardiovascular outcomes

A recent JAMA study has people asking whether abruptly stopping clopidogrel (Plavix) can worsen cardiovascular outcomes.

Acute coronary syndrome patients seem to have about twice the risk of death or heart attack within 90 days of stopping clopidogrel.

Researchers speculate it's a possible "rebound effect."

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote